Antihypertensive agents in Alzheimer's disease: beyond vascular protection
T Lebouvier, Y Chen, P Duriez, F Pasquier… - Expert Review of …, 2020 - Taylor & Francis
Introduction: Midlife hypertension has been consistently linked with increased risk of
cognitive decline and Alzheimer's disease (AD). Observational studies and randomized …
cognitive decline and Alzheimer's disease (AD). Observational studies and randomized …
Sovateltide mediated endothelin B receptors agonism and curbing neurological disorders
Neurological/neurovascular disorders constitute the leading cause of disability and the
second leading cause of death globally. Major neurological/neurovascular disorders or …
second leading cause of death globally. Major neurological/neurovascular disorders or …
Calcium ions aggravate Alzheimer's disease through the aberrant activation of neuronal networks, leading to synaptic and cognitive deficits
PP Guan, LL Cao, Y Yang, P Wang - Frontiers in molecular …, 2021 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disease that is characterized by the
production and deposition of β-amyloid protein (Aβ) and hyperphosphorylated tau, leading …
production and deposition of β-amyloid protein (Aβ) and hyperphosphorylated tau, leading …
Diabetes-related neurological implications and pharmacogenomics
CA Rojas-Carranza, RH Bustos-Cruz… - Current …, 2018 - ingentaconnect.com
Diabetes mellitus (DM) is the most commonly occurring cause of neuropathy around the
world and is beginning to grow in countries where there is a risk of obesity. DM Type …
world and is beginning to grow in countries where there is a risk of obesity. DM Type …
Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
severe cognitive impairment that ultimately leads to death. Endothelin (ET) and its receptors …
severe cognitive impairment that ultimately leads to death. Endothelin (ET) and its receptors …
L-type voltage-dependent calcium channels as therapeutic targets for neurodegenerative diseases
T Yagami, H Kohma… - Current medicinal …, 2012 - ingentaconnect.com
Ca2+ is a highly versatile intracellular second messenger in the central nervous system, and
regulates many complicated cellular processes, including excitation, plasticity and …
regulates many complicated cellular processes, including excitation, plasticity and …
Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death
T Yagami, K Ueda, T Sakaeda, N Itoh… - Biochemical …, 2004 - Elsevier
Amyloid β protein (Aβ)-and human group IIA secretory phospholipase A2 (sPLA2-IIA)-
induced neuronal cell death have been established as in vitro models for Alzheimer's …
induced neuronal cell death have been established as in vitro models for Alzheimer's …
Endothelin systems in the brain: involvement in pathophysiological responses of damaged nerve tissues
Y Koyama - Biomolecular concepts, 2013 - degruyter.com
In addition to their potent vasoconstriction effects, endothelins (ETs) show multiple actions in
various tissues including the brain. The brain contains high levels of ETs, and their …
various tissues including the brain. The brain contains high levels of ETs, and their …
Endothelin-a receptor antagonists prevent amyloid-β-induced increase in ET A receptor expression, oxidative stress, and cognitive impairment
S Briyal, T Philip, A Gulati - Journal of Alzheimer's Disease, 2011 - content.iospress.com
Alzheimer's disease is a neurodegenerative disorder associated with abnormal
accumulation of amyloid-β (Aβ) which can release endothelin (ET). The present study was …
accumulation of amyloid-β (Aβ) which can release endothelin (ET). The present study was …
Targeting endothelin in Alzheimer's disease: a promising therapeutic approach
Endothelin is a chemical mediator that helps in maintaining balance within the blood‐brain
barrier by regulating the levels of toxicants and molecules which pass through the brain …
barrier by regulating the levels of toxicants and molecules which pass through the brain …